Skip to main content
Livermore
Livermore
ZHEN

Citigroup Inc

SEC CIK
0000831001
Latest filing
Aug 3, 2026

APLS holding history

Apellis Pharmaceuticals, Inc. in every 13F filed by Citigroup Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

APLS overviewAll 13F holders of APLSFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of APLS by Citigroup Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−657,223−100.0%Sold outHolders
Q1 2026657,223$26.4M<0.1%+35,065+5.6%AddedHolders
Q4 2025622,158$15.6M<0.1%+177,186+39.8%AddedHolders
Q3 2025444,972$10.1M<0.1%+306,521+221.4%AddedHolders
Q2 2025138,451$2.40M<0.1%−278,168−66.8%ReducedHolders
Q1 2025416,619$9.11M<0.1%+224,458+116.8%AddedHolders
Q4 2024192,161$6.13M<0.1%+179,999+1,480.0%AddedHolders
Q3 202412,162$350.8K<0.1%−30,507−71.5%ReducedHolders
Q2 202442,669$1.64M<0.1%−219,039−83.7%ReducedHolders
Q1 2024261,708$15.4M<0.1%+175,167+202.4%AddedHolders
Q4 202386,541$5.18M<0.1%−30,355−26.0%ReducedHolders
Q3 2023116,896$4.45M<0.1%+36,911+46.1%AddedHolders
Q2 202379,985$7.29M<0.1%−43,422−35.2%ReducedHolders
Q1 2023123,407$8.14M<0.1%+41,307+50.3%AddedHolders
Q4 202282,100$4.25M<0.1%−15,732−16.1%ReducedHolders
Q3 202297,832$6.68M<0.1%−4,128−4.0%ReducedHolders
Q2 2022101,960$4.61M<0.1%+75,276+282.1%AddedHolders
Q1 202226,684$1.36M<0.1%−93,004−77.7%ReducedHolders
Q4 2021119,688$5.66M<0.1%+49,396+70.3%AddedHolders
Q3 202170,292$2.32M<0.1%−22,436−24.2%ReducedHolders
Q2 202192,728$5.86M<0.1%−5,346−5.5%ReducedHolders
Q1 202198,074$4.21M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.